Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,08 USD | -2,26% | -4,42% | +28,80% |
Vakgebied
Aantal werknemers: 93
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 01-01-10 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 01-09-18 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 01-01-17 |
Chief Tech/Sci/R&D Officer | - | 01-08-23 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 02-11-20 |
Murray Stewart
BRD | Director/Board Member | 63 | 29-03-19 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | - | 26-10-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 01-07-18 |
David McGirr
BRD | Director/Board Member | 69 | 01-09-17 |
Paula Ragan
FOU | Founder | 54 | 01-01-10 |
Gary Bridger
BRD | Director/Board Member | 61 | 01-10-18 |
Alison Lawton
BRD | Director/Board Member | 62 | 05-10-20 |
Bill Aliski
BRD | Director/Board Member | 75 | 18-09-19 |
Director/Board Member | 62 | 14-10-21 | |
Murray Stewart
BRD | Director/Board Member | 63 | 29-03-19 |
R. Woods
BRD | Director/Board Member | 57 | 16-10-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 167 937 781 | 162 995 043 ( 97,06 %) | 0 | 97,06 % |
Bedrijfsgegevens
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+28,80% | 186 mln. | |
-1,65% | 104 mld. | |
+6,75% | 97,47 mld. | |
+5,71% | 22,25 mld. | |
-12,60% | 21,68 mld. | |
-9,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-10,17% | 16,36 mld. | |
+6,12% | 14,39 mld. | |
+35,47% | 12,37 mld. |
- Beurs
- Aandelen
- Koers XFOR
- Onderneming X4 Pharmaceuticals, Inc.